| Ytd | -4.01% | |
| 1y | 3.67% |
| Open | 78.17 | Prev Close | 78.07 | Low | 77.60 | High | 78.38 | Mkt Cap | 3.55B |
| Vol | 11.04K | Avg Vol | 892.72K | EPS | 4.97 | P/E | 15.71 | Forward P/E | 14.73 |
| Beta | 0.52 | Short Ratio | 2.83 | Inst. Own | 109.66% | Dividend | N/A | Div Yield | N/A |
| Ex Div Date | N/A | Earning | 08-06 | 50-d Avg | 70.39 | 200-d Avg | 66.36 | 1yr Est | 86.10 |
Mizuho analyst Anthony Petrone maintains Haemonetics (NYSE:HAE) with a Outperform and raises the
Orchestra BioMed Holdings, Inc. (NASDAQ:OBIO, "Orchestra BioMed" or the "Company")),
Companies Reporting Before The Bell • CASI Pharmaceuticals (NASDAQ:CASI) is estimated to report
Stocks That Hit 52-Week Lows On Monday
Stocks that Broke 52-Week Highs Tuesday